These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 7523710
1. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. Ellis WJ, Chetner MP, Preston SD, Brawer MK. J Urol; 1994 Nov; 152(5 Pt 1):1520-5. PubMed ID: 7523710 [Abstract] [Full Text] [Related]
2. Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. Tsui KH, Chang PL, Wang TM, Hsieh ML. Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):23-8. PubMed ID: 9178589 [Abstract] [Full Text] [Related]
3. [Diagnostic algorithm based on a multivariate model to reduce the percentage of negative prostatic biopsies in patients with changed PSA or suspicious rectal palpation]. Valer Algarabel J, Agüera Fernández L, Adot Zurbano JM, Virseda Chamorro M, Marcos Díez J, Gómez López A, Alpuente Román C. Actas Urol Esp; 2000 Mar; 24(7):549-59. PubMed ID: 11011445 [Abstract] [Full Text] [Related]
4. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate. Presti JC, Hovey R, Carroll PR, Shinohara K. J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571 [Abstract] [Full Text] [Related]
11. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate]. Fernández González I, Ruiz Rubio JL, Llorente Abarca C, Aramburu González JA, Montes Díaz MJ, Herrero Payo A, Sánchez Sánchez E, Berenguer Sánchez A. Arch Esp Urol; 1995 May; 48(6):587-94. PubMed ID: 7544968 [Abstract] [Full Text] [Related]
12. [Role of rectal exploration, suprapubic and transrectal prostatic ultrasonography, and PSA in the diagnosis and follow-up of prostatic carcinoma]. Speranza I, Bianco V, Banci M, Muià R, Gianni W, Bacciu O, Vecchione A, Marchei P. Minerva Med; 1998 May; 89(7-8):267-75. PubMed ID: 9824988 [Abstract] [Full Text] [Related]
13. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Gohji K, Nomi M, Egawa S, Morisue K, Takenaka A, Okamoto M, Ohori M, Fujii A. Cancer; 1997 May 15; 79(10):1969-76. PubMed ID: 9149025 [Abstract] [Full Text] [Related]
14. Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels. Dinçel C, Caşkurlu T, Taşçi AI, Cek M, Sevin G, Fazlioğlu A. Int Urol Nephrol; 1999 May 15; 31(4):497-509. PubMed ID: 10668945 [Abstract] [Full Text] [Related]
15. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy]. Di Donna A, Bazzocchi M, Guerra UP, Bendini M, De Biasi F, Caminiti F, Delendi M. Radiol Med; 1993 May 15; 85(1-2):84-9. PubMed ID: 7683136 [Abstract] [Full Text] [Related]
16. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations. Presti JC, Hovey R, Bhargava V, Carroll PR, Shinohara K. J Urol; 1997 Mar 15; 157(3):907-11; discussion 911-2. PubMed ID: 9072597 [Abstract] [Full Text] [Related]
17. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A. J Urol; 2001 Oct 15; 166(4):1339-42. PubMed ID: 11547069 [Abstract] [Full Text] [Related]
18. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. Cookson MS, Floyd MK, Ball TP, Miller EK, Sarosdy MF. J Urol; 1995 Sep 15; 154(3):1070-3. PubMed ID: 7543601 [Abstract] [Full Text] [Related]
19. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC. J Urol; 1994 Dec 15; 152(6 Pt 1):2031-6. PubMed ID: 7525994 [Abstract] [Full Text] [Related]
20. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. Yuan JJ, Coplen DE, Petros JA, Figenshau RS, Ratliff TL, Smith DS, Catalona WJ. J Urol; 1992 Mar 15; 147(3 Pt 2):810-4. PubMed ID: 1371553 [Abstract] [Full Text] [Related] Page: [Next] [New Search]